Artiva Biotherapeutics (ARTV) Equity Ratio (2023 - 2025)
Historic Equity Ratio for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to 0.87.
- Artiva Biotherapeutics' Equity Ratio fell 256.76% to 0.87 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.87, marking a year-over-year decrease of 256.76%. This contributed to the annual value of 0.89 for FY2024, which is 15777.77% up from last year.
- Artiva Biotherapeutics' Equity Ratio amounted to 0.87 in Q3 2025, which was down 256.76% from 0.88 recorded in Q2 2025.
- Over the past 5 years, Artiva Biotherapeutics' Equity Ratio peaked at 0.89 during Q3 2024, and registered a low of 2.52 during Q2 2024.
- For the 3-year period, Artiva Biotherapeutics' Equity Ratio averaged around 0.05, with its median value being 0.88 (2025).
- Its Equity Ratio has fluctuated over the past 5 years, first soared by 15777.77% in 2024, then crashed by 256.76% in 2025.
- Over the past 3 years, Artiva Biotherapeutics' Equity Ratio (Quarter) stood at 1.54 in 2023, then skyrocketed by 157.78% to 0.89 in 2024, then fell by 2.52% to 0.87 in 2025.
- Its last three reported values are 0.87 in Q3 2025, 0.88 for Q2 2025, and 0.88 during Q1 2025.